213 related articles for article (PubMed ID: 28604662)
1. Upregulation of mitochondrial NAD
Son MJ; Ryu JS; Kim JY; Kwon Y; Chung KS; Mun SJ; Cho YS
Exp Mol Med; 2017 Jun; 49(6):e344. PubMed ID: 28604662
[TBL] [Abstract][Full Text] [Related]
2. Interplay between TRAP1 and Sirtuin-3 Modulates Mitochondrial Respiration and Oxidative Stress to Maintain Stemness of Glioma Stem Cells.
Park HK; Hong JH; Oh YT; Kim SS; Yin J; Lee AJ; Chae YC; Kim JH; Park SH; Park CK; Park MJ; Park JB; Kang BH
Cancer Res; 2019 Apr; 79(7):1369-1382. PubMed ID: 30683653
[TBL] [Abstract][Full Text] [Related]
3. Restoration of Mitochondrial NAD
Son MJ; Kwon Y; Son T; Cho YS
Stem Cells; 2016 Dec; 34(12):2840-2851. PubMed ID: 27428041
[TBL] [Abstract][Full Text] [Related]
4. A spontaneous mutation in the nicotinamide nucleotide transhydrogenase gene of C57BL/6J mice results in mitochondrial redox abnormalities.
Ronchi JA; Figueira TR; Ravagnani FG; Oliveira HC; Vercesi AE; Castilho RF
Free Radic Biol Med; 2013 Oct; 63():446-56. PubMed ID: 23747984
[TBL] [Abstract][Full Text] [Related]
5. CDC20 maintains tumor initiating cells.
Xie Q; Wu Q; Mack SC; Yang K; Kim L; Hubert CG; Flavahan WA; Chu C; Bao S; Rich JN
Oncotarget; 2015 May; 6(15):13241-54. PubMed ID: 25938542
[TBL] [Abstract][Full Text] [Related]
6. Reactive species balance via GTP cyclohydrolase I regulates glioblastoma growth and tumor initiating cell maintenance.
Tran AN; Walker K; Harrison DG; Chen W; Mobley J; Hocevar L; Hackney JR; Sedaka RS; Pollock JS; Goldberg MS; Hambardzumyan D; Cooper SJ; Gillespie Y; Hjelmeland AB
Neuro Oncol; 2018 Jul; 20(8):1055-1067. PubMed ID: 29409010
[TBL] [Abstract][Full Text] [Related]
7. MCU-dependent mitochondrial Ca
Ren T; Zhang H; Wang J; Zhu J; Jin M; Wu Y; Guo X; Ji L; Huang Q; Zhang H; Yang H; Xing J
Oncogene; 2017 Oct; 36(42):5897-5909. PubMed ID: 28650465
[TBL] [Abstract][Full Text] [Related]
8. SIRT3, a mitochondrial NAD⁺-dependent deacetylase, is involved in the regulation of myoblast differentiation.
Abdel Khalek W; Cortade F; Ollendorff V; Lapasset L; Tintignac L; Chabi B; Wrutniak-Cabello C
PLoS One; 2014; 9(12):e114388. PubMed ID: 25489948
[TBL] [Abstract][Full Text] [Related]
9. Converting NADH to NAD+ by nicotinamide nucleotide transhydrogenase as a novel strategy against mitochondrial pathologies during aging.
Olgun A
Biogerontology; 2009 Aug; 10(4):531-4. PubMed ID: 18932012
[TBL] [Abstract][Full Text] [Related]
10. DJ-1 Contributes to Self-renewal of Stem Cells in the U87-MG Glioblastoma Cell Line.
Toda Y; Yoshimura R; Itahara M; Imai Y; Yamada K; Uno T; Nakata S; Hosogi S; Takata K; Ashihara E
Anticancer Res; 2019 Nov; 39(11):5983-5990. PubMed ID: 31704823
[TBL] [Abstract][Full Text] [Related]
11. Girdin maintains the stemness of glioblastoma stem cells.
Natsume A; Kato T; Kinjo S; Enomoto A; Toda H; Shimato S; Ohka F; Motomura K; Kondo Y; Miyata T; Takahashi M; Wakabayashi T
Oncogene; 2012 May; 31(22):2715-24. PubMed ID: 22020337
[TBL] [Abstract][Full Text] [Related]
12. Metabolic activation of mitochondria in glioma stem cells promotes cancer development through a reactive oxygen species-mediated mechanism.
Yuan S; Lu Y; Yang J; Chen G; Kim S; Feng L; Ogasawara M; Hammoudi N; Lu W; Zhang H; Liu J; Colman H; Lee JS; Li XN; Xu RH; Huang P; Wang F
Stem Cell Res Ther; 2015 Oct; 6():198. PubMed ID: 26472041
[TBL] [Abstract][Full Text] [Related]
13. Reducing VDAC1 expression induces a non-apoptotic role for pro-apoptotic proteins in cancer cell differentiation.
Arif T; Krelin Y; Shoshan-Barmatz V
Biochim Biophys Acta; 2016 Aug; 1857(8):1228-1242. PubMed ID: 27080741
[TBL] [Abstract][Full Text] [Related]
14. Metabolic heterogeneity and plasticity of glioma stem cells in a mouse glioblastoma model.
Shibao S; Minami N; Koike N; Fukui N; Yoshida K; Saya H; Sampetrean O
Neuro Oncol; 2018 Feb; 20(3):343-354. PubMed ID: 29016888
[TBL] [Abstract][Full Text] [Related]
15. Nicotinamide Nucleotide Transhydrogenase as a Sensor of Mitochondrial Biology.
Nesci S; Trombetti F; Pagliarani A
Trends Cell Biol; 2020 Jan; 30(1):1-3. PubMed ID: 31753532
[TBL] [Abstract][Full Text] [Related]
16. Aptamer identification of brain tumor-initiating cells.
Kim Y; Wu Q; Hamerlik P; Hitomi M; Sloan AE; Barnett GH; Weil RJ; Leahy P; Hjelmeland AB; Rich JN
Cancer Res; 2013 Aug; 73(15):4923-36. PubMed ID: 23796560
[TBL] [Abstract][Full Text] [Related]
17. Nicotinamide nucleotide transhydrogenase is required for brain mitochondrial redox balance under hampered energy substrate metabolism and high-fat diet.
Francisco A; Ronchi JA; Navarro CDC; Figueira TR; Castilho RF
J Neurochem; 2018 Dec; 147(5):663-677. PubMed ID: 30281804
[TBL] [Abstract][Full Text] [Related]
18. Temozolomide-induced increase of tumorigenicity can be diminished by targeting of mitochondria in in vitro models of patient individual glioblastoma.
William D; Walther M; Schneider B; Linnebacher M; Classen CF
PLoS One; 2018; 13(1):e0191511. PubMed ID: 29352318
[TBL] [Abstract][Full Text] [Related]
19. Sox11 prevents tumorigenesis of glioma-initiating cells by inducing neuronal differentiation.
Hide T; Takezaki T; Nakatani Y; Nakamura H; Kuratsu J; Kondo T
Cancer Res; 2009 Oct; 69(20):7953-9. PubMed ID: 19808959
[TBL] [Abstract][Full Text] [Related]
20. PKCδ maintains phenotypes of tumor initiating cells through cytokine-mediated autocrine loop with positive feedback.
Kim RK; Suh Y; Hwang E; Yoo KC; Choi KS; An S; Hwang SG; Kim IG; Kim MJ; Lee HJ; Lee SJ
Oncogene; 2015 Nov; 34(46):5749-59. PubMed ID: 25746003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
